Targeted drug trial aims to control aggressive brain metastases
NCT ID NCT04992013
Summary
This study is testing whether the drug niraparib can help control cancer that has spread to the brain or spinal cord. It will involve about 20 adults whose cancer has specific genetic changes and has progressed despite other treatments. Participants will take the oral medication for up to two years while researchers monitor how it affects their brain tumors and overall health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.